I dunno, its stupid whatever it is, but no, FB would love to own it. Its what all the kids are using and ad revenue is thru the roof. Current WS mantra is its 'the next FB'. Apparently whatever generation we're on now, the under 20 folks, are loyal to what they like. FB is your grandfather's Buick. Big companies like P&G like to cultivate loyal consumers early. SNAP gets those big ad dollars now. Who's gonna train the drivers to administer whatever? Microsoft bought em in 2016.
Well... Here we are folks... it's time to take global warming seriously. This is how you pronounce Anastassia's last name in case you meet up with her. Don't screw it up. mironchikivanova 981posts 37.5kfollowers and stoney! 1,112following Me again! Mironchik-Ivanova Long Jumper Ambassador@nike • World Championship • European Indoor Championship • European Games • Board Member gummybear advisors
Van where are you? --Sinclair Broadcast reports Q3 consolidated adjusted EBITDA $736M, up 97% y/y 07:35 SBGI WTF! NJ goes for POT!!!! YES! Moving to NJ.... - TRSSF--?
????--> Is this a typo? $42.60 as a loss? That's the biggest dollar loss I have seen in my 30 + years.... What is going on. WHO WON THE ELECTION??? Sinclair Broadcast reports Q3 EPS ($42.66) vs. (64c) a year ago 07:32 SBGI Reports Q3 revenue $1.54B, consensus $1.51B. The impact of sdjustments in the third quarter of 2020, on a diluted per-share basis, was ($44.79) and the impact of adjustments in the third quarter of 2019 was ($1.79). Show Related Items >>
TA is a good stock I have used before. When trucking is going good so is this play on R&R for truck drivers. TravelCenters reports Q3 EPS 65c, consensus 25c » Big beat!
This has been one of my pet bios over the last ten years I have been inb and out maybe five times... I like management. Ionis Pharmaceuticals 'on track' to being 'meaningfully profitable this year' 07:04 IONS "Our acquisition of Akcea further strengthens our business and financial position in numerous ways. We now retain more value from Akcea's rich pipeline and commercial products. We are also able to use Akcea's current cash and future cash flows to advance Ionis' strategic priorities. And beginning next year, we expect to realize meaningful cost synergies as we continue to integrate the two companies," said Elizabeth Hougen, CFO of Ionis. "Looking ahead, we are maintaining our 2020 financial guidance driven by the significant revenue and earnings growth we expect in the fourth quarter. We have already earned revenue from multiple sources this quarter, including $75 million from Pfizer for advancing vupanorsen. Importantly, we remain well capitalized with the financial resources to achieve our strategic goals."
VAN SHORT SCOTTS MIRACLE GROW!!! A)LETS START A GUMMY SHORT PORTFOLIO-! B) YOUR GRANDMA'S PORTFOLO -! C ) AND I WILL COME UP WITH A GANJA & biotech/Testing PORTFOLIO...-!
This is the ugly duck of the CRSP world... uniQure assumed with an Overweight at Cantor Fitzgerald 07:02 QURE Cantor Fitzgerald analyst Kristen Kluska assumed coverage of uniQure with an Overweight rating and $65 price target. Kluska believes investor expectations for a positive readout of top-line Phase 3 EtranaDez data is high and believes this is a key catalyst and further underscores the significant execution uniQure's management team has made since late 2017. The analyst believes CSL Behring represents a "great" partner to maximize the opportunity in hemophilia B.